A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial to Compare Chemotherapy With Capecitabine and Oxaliplatin for 4 Months to 6 Months After D2 Gastrectomy for Gastric Cancer Staged II or III.

Trial Profile

A Prospective,Multicentral,Open-label,Randomized,Controlled,Phase III Clinical Trial to Compare Chemotherapy With Capecitabine and Oxaliplatin for 4 Months to 6 Months After D2 Gastrectomy for Gastric Cancer Staged II or III.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Jan 2018

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
  • Indications Adenocarcinoma; Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top